학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 128건 | 목록
1~20
Academic Journal
Berg, Staffan; Uggla, Teresia; Antonsson, Malin; Nunes, Sandro Filipe; Englund, Maria; Rosengren, Louise; Fahraj, Masoud; Wu, Xiaoqiu; Govender, Rydvikha; Söderberg, Magnus; Janzén, David; Van Zuydam, Natalie; Hugerth, Andreas; Larsson, Anette; Abrahmsén-Alami, Susanna; Abrahamsson, Bertil; Davies, Nigel; Bergström, Christel A. S., 1973
Journal of Controlled Release. 353:792-801
Academic Journal
Maclean N; CMAC, University of Strathclyde, Glasgow, UK.; Abrahmsén-Alami S; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.; Clark C; CMAC, University of Strathclyde, Glasgow, UK.; Dörr F; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.; Florence A; CMAC, University of Strathclyde, Glasgow, UK.; Ketolainen J; School of Pharmacy, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.; Lindow M; Center for Pharmaceutical Data Science Education, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.; Mantanus J; CMC Development Sciences, Materials Science, UCB Pharma, Braine-L'Alleud, Belgium.; Rantanen J; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark; Center for Pharmaceutical Data Science Education, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.; Reynolds G; Sustainable Innovation & Transformational Excellence (xSITE), Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.; Robertson A; Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.; Markl D; CMAC, University of Strathclyde, Glasgow, UK. Electronic address: daniel.markl@strath.ac.uk.
Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE
Academic Journal
Karttunen, A.-P. ; Poms, J. ; Sacher, S. ; Sparén, A. ; Ruiz Samblás, C. ; Fransson, M. ; Martin De Juan, L. ; Remmelgas, J. ; Wikström, H. ; Hsiao, W-K. ; Folestad, S. ; Korhonen, O. ; Abrahmsén-Alami, S. ; Tajarobi, P.
In International Journal of Pharmaceutics 25 January 2020 574
Academic Journal
Olsson, Martina ; Govender, Rydvikha ; Diaz, Ana ; Holler, Mirko ; Menzel, Andreas ; Abrahmsén-Alami, Susanna ; Sadd, Matthew ; Larsson, Anette ; Matic, Aleksandar ; Liebi, Marianne
In International Journal of Pharmaceutics 25 July 2023 642
Academic Journal
Gels. September, 2022, Vol. 8 Issue 9
Academic Journal
Journal of Controlled Release. 311-312:117-124
Academic Journal
Alva C; Research Center Pharmaceutical Engineering GmbH, Graz, Austria; Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, University of Graz, Graz, Austria.; Goetzinger E; Research Center Pharmaceutical Engineering GmbH, Graz, Austria; Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, University of Graz, Graz, Austria.; Matić J; Research Center Pharmaceutical Engineering GmbH, Graz, Austria.; Doğan A; Research Center Pharmaceutical Engineering GmbH, Graz, Austria.; Slama E; Research Center Pharmaceutical Engineering GmbH, Graz, Austria.; Heupl S; FH Upper Austria Research & Development GmbH, Wels, Austria.; Rillmann T; IOI Oleo GmbH, Witten, Germany.; Abrahmsén-Alami S; Sustainable Innovation and Transformational Excellence, Pharmaceutical Technology and Development, Operations, AstraZeneca, Gothenburg, Sweden.; Booth J; New Modalities and Parenteral Product Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, Macclesfield, United Kingdom.; Salar-Behzadi S; Research Center Pharmaceutical Engineering GmbH, Graz, Austria; Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, University of Graz, Graz, Austria. Electronic address: Sharareh.salar@rcpe.at.; Spoerk M; Research Center Pharmaceutical Engineering GmbH, Graz, Austria; Institute of Process and Particle Engineering, Graz University of Technology, Graz, Austria. Electronic address: martin.spoerk@rcpe.at.
Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
Academic Journal
Whiteley J; School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, U.K.; Abrahmsén-Alami S; Sustainable Innovation & Transformational Excellence, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg SE-431 83, Sweden.; Booth J; New Modalities & Parenterals Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Charter Way, Macclesfield SK10 2NA, U.K.; Mellor S; Croda Europe Ltd, Cowick Hall, Snaith, Goole DN14 9AA, U.K.; Humphrey J; Croda Europe Ltd, Cowick Hall, Snaith, Goole DN14 9AA, U.K.; Waters LJ; School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, U.K.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Academic Journal
Vaitukaitis, Povilas (S-CHAL-MMT) AMS Author Profile; Maggiolo, Dario (S-CHAL-MMT) AMS Author Profile; Remmelgas, Johan (S-ASTRA-PHT) AMS Author Profile; Abrahmsén-Alami, Susanna (S-ASTRA-PHT) AMS Author Profile; Bernin, Diana (S-CHAL-KKE) AMS Author Profile; Siiskonen, Maria (S-CHAL-IMT) AMS Author Profile; Malmqvist, Johan (S-CHAL-IMT) AMS Author Profile; Sasic, Srdjan (S-CHAL-MMT) AMS Author Profile; Sardina, Gaetano (S-CHAL-MMT) AMS Author Profile
Academic Journal
In Journal of Pharmaceutical Sciences January 2022 111(1):185-196
Academic Journal
European Journal of Pharmaceutical Sciences. 37:89-97
Academic Journal
Wanselius M; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden.; Abrahmsén-Alami S; Innovation Strategy & External Liaison. Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden.; Hanafy BI; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca Cambridge, United Kingdom.; Mazza M; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca Cambridge, United Kingdom.; Hansson P; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden. Electronic address: per.hansson@ilk.uu.se.
Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE
Govender R; Pharmaceutical Technology and Development, AstraZeneca, Pepparedsleden 1, 43183, Gothenburg, Mölndal, Sweden. rydvikha.govender@astrazeneca.com.; Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, Sweden. rydvikha.govender@astrazeneca.com.; Abrahmsén-Alami S; Pharmaceutical Technology and Development, AstraZeneca, Pepparedsleden 1, 43183, Gothenburg, Mölndal, Sweden.; Folestad S; Pharmaceutical Technology and Development, AstraZeneca, Pepparedsleden 1, 43183, Gothenburg, Mölndal, Sweden.; Larsson A; Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Journal of Colloid and Interface Science. 189:137-143
Academic Journal
JOURNAL OF PHYSICAL CHEMISTRY. 100(16):6691-6697
Academic Journal
The Journal of Physical Chemistry. 100:4598-4605
Academic Journal
Nyström L; Chemical Processes and Pharmaceutical Development, RISE, 114 28 Stockholm, Sweden.; Mira I; Chemical Processes and Pharmaceutical Development, RISE, 114 28 Stockholm, Sweden.; Benjamins JW; Chemical Processes and Pharmaceutical Development, RISE, 114 28 Stockholm, Sweden.; Gopaul S; DMPK, Early Cardiovascular and Metabolic Diseases, Biopharmaceutical R&D, AstraZeneca Gothenburg, 431 83 Mölndal, Sweden.; Granfeldt A; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, 431 83 Mölndal, Sweden.; Abrahamsson B; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, 431 83 Mölndal, Sweden.; von Corswant C; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, 431 83 Mölndal, Sweden.; Abrahmsén-Alami S; Sustainable Innovation & Transformational Excellence, Pharmaceutical Technology & Development, Operations, AstraZeneca Gothenburg, 431 83 Mölndal, Sweden.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Academic Journal
McGowan A; DelSiTech Ltd., PharmaCity, Itäinen Pitkäkatu 4 B, 20520 Turku, Finland.; Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping 581 83, Sweden.; Akieh-Pirkanniemi M; DelSiTech Ltd., PharmaCity, Itäinen Pitkäkatu 4 B, 20520 Turku, Finland.; Wirman L; DelSiTech Ltd., PharmaCity, Itäinen Pitkäkatu 4 B, 20520 Turku, Finland.; Davies N; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.; Elebring M; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.; Tivesten A; CVRM CMC Projects, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.; Strimfors M; Bioscience metabolism, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.; Hölttä M; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.; Söderberg M; Pathology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.; Berntsson V; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.; Balas D; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.; Koskinen M; DelSiTech Ltd., PharmaCity, Itäinen Pitkäkatu 4 B, 20520 Turku, Finland.; Leino L; DelSiTech Ltd., PharmaCity, Itäinen Pitkäkatu 4 B, 20520 Turku, Finland.; Abrahmsén-Alami S; Sustainable Innovation & Transformational Excellence, Pharmaceutical Technology & Development, Operations, AstraZeneca, Mölndal, Gothenburg SE-431 83, Sweden.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Academic Journal
European Journal of Pharmaceutical Sciences. May 01, 2009 37(2):89-97
Academic Journal
Govender R; Pharmaceutical Technology and Development, AstraZeneca Gothenburg, Pepparedsleden 1, 43183, Mölndal, Sweden. rydvikha.govender@astrazeneca.com.; Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, Sweden. rydvikha.govender@astrazeneca.com.; Abrahmsén-Alami S; Pharmaceutical Technology and Development, AstraZeneca Gothenburg, Pepparedsleden 1, 43183, Mölndal, Sweden.; Folestad S; Pharmaceutical Technology and Development, AstraZeneca Gothenburg, Pepparedsleden 1, 43183, Mölndal, Sweden.; Larsson A; Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Abrahmsén-Alami, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어